BlackRock’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-5,285
Closed -$10K 3917
2016
Q1
$10K Buy
5,285
+3,199
+153% +$5.71K ﹤0.01% 3183
2015
Q4
$4K Buy
2,086
+93
+5% +$276 ﹤0.01% 3233
2015
Q3
$6K Hold
1,993
﹤0.01% 2981
2015
Q2
$7K Hold
1,993
﹤0.01% 3041
2015
Q1
$6K Hold
1,993
﹤0.01% 3006
2014
Q4
$6K Hold
1,993
﹤0.01% 3037
2014
Q3
$14K Hold
1,993
﹤0.01% 2552
2014
Q2
$23K Sell
1,993
-79,157
-98% -$844K ﹤0.01% 2309
2014
Q1
$942K Buy
81,150
+79,720
+5,575% +$938K ﹤0.01% 1215
2013
Q4
$15K Hold
1,430
﹤0.01% 2520
2013
Q3
$15K Hold
1,430
﹤0.01% 2425
2013
Q2
$16K Buy
+1,430
New +$14.3K ﹤0.01% 2427

BlackRock's SZYM Position: Q2 2016 in Review

BlackRock sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 5,285 shares — an estimated $10K sold.

BlackRock first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $942K in Q1 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • BlackRock reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • BlackRock sold 5,285 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $10K.
  • BlackRock first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • BlackRock's SOLAZYME INC COM STK (DE) position peaked at $942K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on BlackRock's 13F filing for Q2 2016, filed 10 Aug 2016.